Biology subjects

Giles, L.

Publications and source records attributed to Giles, L..

3 recordsLinked to original sources

bioRxiv2026

Stitching genomics data to protein structures: Virulence factors in non-O157 Shiga toxin-producing Escherichia coli

The genetic diversity of the Shiga toxin-producing Escherichia coli (STEC) sub-species group poses major challenges for assigning pathogenic potential, and for accurate diagnostics. Although existing risk-based frameworks work for the predominant serotypes e.g. STEC O157 or O26, they are less useful for more diverse genotypes, with variation in the genetic complement of virulence factors that is responsible for disease outcome. Moreover, genetic diversity occurs at the virulence factor allele level. We investigated the functional potential of genetic variation at a whole genome level and at an allele variant level, based on the premise that genomic variability underlies phenotypic traits including disease outcomes. We analysed 286 non-O157 STEC genomes for their virulence factor complement and determined co-occurrence patterns. Genetic variation in the well-characterized virulence factor intimin (eae) and its receptor (tir) was analyzed at a sequence level, and by modelling the three-dimensional protein-protein complex using AlphaFold3 and homology modelling. Different subtypes of Eae were shown to preserve their interaction with the receptor Tir by retaining the interactions at the protein-protein interface. The study shows that virulence factor characterisation in association with 3-D modelling of protein complexes can aid genomic analysis for risk assessment, and inform on functional mechanisms for pathogenicity.

bioinformatics↗

bioRxiv2021

Ectopic FVIII expression and misfolding in hepatocytes as a potential cause of human hepatocellular carcinoma

Hemophilia A gene therapy targets hepatocytes to express B domain deleted-(BDD) clotting factor VIII (FVIII) to permit viral encapsidation. Since BDD is prone to misfolding in the endoplasmic reticulum (ER) and ER protein misfolding in hepatocytes followed by high fat diet (HFD) can cause hepatocellular carcinoma (HCC), we studied how FVIII misfolding impacts HCC development using hepatocyte DNA delivery to express three proteins from the same parental vector: 1) well-folded cytosolic dihydrofolate reductase (DHFR); 2) BDD-FVIII, which is prone to misfolding in the ER; and 3) N6-FVIII which folds more efficiently than BDD-FVIII. One week after DNA delivery, when FVIII expression was undetectable, mice were fed HFD for 65 weeks. Remarkably, all mice that received BDD-FVIII vector developed liver tumors, whereas only 58% of mice that received N6 and no mice that received DHFR vector developed liver tumors, suggesting that the degree of protein misfolding in the ER increases predisposition to HCC in the context of a HFD and in the absence of viral transduction. Our findings raise concerns of ectopic BDD-FVIII expression in hepatocytes in the clinic, which poses risks independent of viral vector integration. Limited expression per hepatocyte and/or use of proteins that avoid misfolding may enhance safety. Graphical abstract O_FIG_DISPLAY_L [Figure 1] M_FIG_DISPLAY C_FIG_DISPLAY

cancer biology↗

bioRxiv2018

Assessing the effect of hypoxia on cardiac metabolism using hyperpolarized 13C magnetic resonance spectroscopy

Abstract summaryHypoxia plays a role in many diseases and can have a wide range of effects on cardiac metabolism depending on the extent of the hypoxic insult. Non-invasive imaging methods could shed valuable light on the metabolic effects of hypoxia on the heart in vivo. Hyperpolarized carbon-13 magnetic resonance spectroscopy (HP 13C MRS) in particular is an exciting technique for imaging metabolism that could provide such information.\n\nThe aim of our work was, therefore, to establish whether hyperpolarized 13C MRS can be used to assess the in vivo response of cardiac metabolism to systemic acute and chronic hypoxic exposure. Groups of healthy male Wistar rats were exposed to either acute (30 minutes), one week or three weeks of hypoxia. In vivo MRS of hyperpolarized [1-13C]pyruvate was carried out along with assessments of physiological parameters and ejection fraction. No significant changes in heart rate, respiration rate, or ejection fraction were observed at any timepoint. Haematocrit was elevated after one week and three weeks of hypoxia.\n\nThirty minutes of hypoxia resulted in a significant reduction in pyruvate dehydrogenase (PDH) flux, whereas one or three weeks of hypoxia resulted in a PDH flux that was not different to normoxic animals. Conversion of hyperpolarized [1-13C]pyruvate into [1-13C]lactate was elevated following acute hypoxia, suggestive of enhanced anaerobic glycolysis. Elevated HP pyruvate to lactate conversion was also seen at the one-week timepoint, in concert with an increase in lactate dehydrogenase (LDH) expression. Following three weeks of hypoxic exposure, cardiac metabolism was comparable to that observed in normoxia.\n\nWe have successfully visualized of the effects of systemic hypoxia on cardiac metabolism using hyperpolarized 13C MRS, with differences observed following 30 minutes and 1 week of hypoxia. This demonstrates the potential of in vivo hyperpolarized 13C MRS data for assessing the cardiometabolic effects of hypoxia in disease.

physiology↗